197 related articles for article (PubMed ID: 19356801)
1. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.
Zdravkovic N; Shahin A; Arsenijevic N; Lukic ML; Mensah-Brown EP
Mol Immunol; 2009 Nov; 47(1):28-36. PubMed ID: 19356801
[TBL] [Abstract][Full Text] [Related]
2. ST2 gene-deletion reveals a role of Foxp3+ regulatory T cells in diabetes modulation in BALB/c mice.
Zdravkovic N; Pavlovic S; Zdravkovic V; Pejnovic N; Arsenijevic N; Lukic ML
Transl Res; 2013 Feb; 161(2):118-29. PubMed ID: 23142275
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
Müller A; Schott-Ohly P; Dohle C; Gleichmann H
Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
[TBL] [Abstract][Full Text] [Related]
4. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
Front Immunol; 2018; 9():2646. PubMed ID: 30498495
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
Herold KC; Vezys V; Sun Q; Viktora D; Seung E; Reiner S; Brown DR
J Immunol; 1996 May; 156(9):3521-7. PubMed ID: 8617981
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
Ablamunits V; Quintana F; Reshef T; Elias D; Cohen IR
J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
[TBL] [Abstract][Full Text] [Related]
8. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin.
Mensah-Brown EP; Shahin A; Al-Shamisi M; Wei X; Lukic ML
Eur J Immunol; 2006 Jan; 36(1):216-23. PubMed ID: 16358360
[TBL] [Abstract][Full Text] [Related]
9. Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice.
Carlos D; Yaochite JN; Rocha FA; Toso VD; Malmegrim KC; Ramos SG; Jamur MC; Oliver C; Camara NO; Andrade MV; Cunha FQ; Silva JS
Eur J Immunol; 2015 Oct; 45(10):2873-85. PubMed ID: 26234742
[TBL] [Abstract][Full Text] [Related]
10. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
[TBL] [Abstract][Full Text] [Related]
11. Functional capacity of macrophages determines the induction of type 1 diabetes.
Mensah-Brown E; Shahin A; Parekh K; Hakim AA; Shamisi MA; Hsu DK; Lukic ML
Ann N Y Acad Sci; 2006 Nov; 1084():49-57. PubMed ID: 17151292
[TBL] [Abstract][Full Text] [Related]
12. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
14. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
15. Carbenoxolone Could Deteriorate Streptozotocin-induced Diabetes through Induction of Heat Shock Protein 70 and IFN-γ in C57BL/6 Mice.
Rasouli M; Jafari-Khataylou Y; Ashrafi-Helan J
Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):564-573. PubMed ID: 30644701
[TBL] [Abstract][Full Text] [Related]
16. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
Huang X; Du W; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
[TBL] [Abstract][Full Text] [Related]
17. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
[TBL] [Abstract][Full Text] [Related]
18. Effect of schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes.
El-Wakil HS; Aboushousha TS; El Haddad O; Gamil NB; Mansour T; El-Said H
J Egypt Soc Parasitol; 2002 Dec; 32(3):987-1002. PubMed ID: 12512830
[TBL] [Abstract][Full Text] [Related]
19. 11-Keto-β-Boswellic Acids Prevent Development of Autoimmune Reactions, Insulitis and Reduce Hyperglycemia During Induction of Multiple Low-Dose Streptozotocin (MLD-STZ) Diabetes in Mice.
Shehata AM; Quintanilla-Fend L; Bettio S; Jauch J; Scior T; Scherbaum WA; Ammon HP
Horm Metab Res; 2015 Jun; 47(6):463-9. PubMed ID: 25951322
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells.
Singh K; Kadesjö E; Lindroos J; Hjort M; Lundberg M; Espes D; Carlsson PO; Sandler S; Thorvaldson L
Sci Rep; 2015 Jul; 5():12633. PubMed ID: 26224624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]